Managing frail patients with myeloma: assessing frailty and personalizing treatment

Mohamad Mohty, MD, PhD, Saint-Antoine Hospital, Paris, France, provides insight into the complexities of treating frail patients with multiple myeloma (MM), noting that frailty is a multifactorial concept involving comorbidities, psychological and cognitive factors, as well as social environment. Prof. Mohty emphasizes that carefully assessing frailty is essential, as treatment approaches should balance efficacy with potential toxicity, and highlights that frailty is a dynamic parameter that can change over time. This interview took place at the 21st International Myeloma Society (IMS) Annual Meeting, held in Rio de Janeiro, Brazil.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.